UK to introduce continuous monitoring of AI-powered medical devices

0
40
UK strengthens AI healthcare safety rules with continuous medical devices monitoring | Reuters
UK strengthens AI healthcare safety rules with continuous medical devices monitoring | Reuters

The United Kingdom plans to strengthen the safety oversight of artificial intelligence-powered medical devices by requiring continuous monitoring after approval, moving beyond the traditional approach of relying on a single pre-approval safety assessment.

The government has accepted all 44 recommendations from a report outlining changes to the approval and regulation of AI-based medical tools. It plans to publish a comprehensive implementation roadmap by spring 2027, with a draft expected by the end of 2026.

The roadmap will establish delivery targets and timelines for implementing the recommended changes across the National Health Service (NHS).

The UK is the first country to develop comprehensive rules for this emerging technology. Lawrence Tallon, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said several countries are approaching the UK to understand and learn from its regulatory approach.

“We’re moving into a much more sophisticated and complex era of AI as a medical device where we have non-deterministic algorithms,” Tallon said. He was referring to AI systems that can evolve and adapt while doctors are using them, creating new challenges for safety monitoring and regulation.

As AI becomes more advanced in healthcare, regulators face the challenge of ensuring that medical devices remain safe and reliable throughout their use, including when their behaviour changes over time.

The MHRA will also begin accepting applications for the 3rd phase of its AI Airlock programme. This phase will focus on post-market surveillance and lifecycle monitoring, allowing regulators to assess AI medical devices after they enter clinical practice.

The proposed measures aim to strengthen oversight throughout the lifecycle of AI-powered medical devices and help ensure that their safety remains a priority after they are approved for use.

Also read: Viksit Workforce for a Viksit Bharat

Do Follow: The Mainstream LinkedIn | The Mainstream Facebook | The Mainstream Youtube | The Mainstream Twitter

About us:

The Mainstream is a premier platform delivering the latest updates and informed perspectives across the technology business and cyber landscape. Built on research-driven, thought leadership and original intellectual property, The Mainstream also curates summits & conferences that convene decision makers to explore how technology reshapes industries and leadership. With a growing presence in India and globally across the Middle East, Africa, ASEAN, the USA, the UK and Australia, The Mainstream carries a vision to bring the latest happenings and insights to 8.2 billion people and to place technology at the centre of conversation for leaders navigating the future.